Anti-Avian Influenza Matrix蛋白I抗体(ab25918)
Key features and details
- Rabbit polyclonal to Avian Influenza Matrix Protein I
- Suitable for: WB, ICC/IF
- Reacts with: Influenza A
- Isotype: IgG
概述
-
产品名称
Anti-Avian Influenza Matrix蛋白I抗体
参阅全部 Avian Influenza Matrix Protein I 一抗 -
描述
兔多克隆抗体to Avian Influenza Matrix蛋白I -
宿主
Rabbit -
经测试应用
适用于: WB, ICC/IFmore details -
种属反应性
与反应: Influenza A -
免疫原
Synthetic peptide:
SGPLKAEIAQRLEDVFAGKN
, corresponding to amino acids 9-28 of Chicken Avian Influenza Matrix Protein 1. -
阳性对照
- Recombinant fusion protein.
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
存储溶液
pH: 7.4
Preservative: 0.05% Sodium azide
Constituent: 0.05% BSA -
Concentration information loading... -
纯度
Protein G purified -
纯化说明
This antibody was purified by chromatography. -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab25918于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度；实际最佳的稀释度/浓度应由使用者检定。
| 应用 | Ab评论 | 说明 |
|---|---|---|
| WB |
Use a concentration of 0.5 - 2 µg/ml. Predicted molecular weight: 27 kDa.
|
|
| ICC/IF |
1/10.
|
| 说明 |
|---|
|
WB
Use a concentration of 0.5 - 2 µg/ml. Predicted molecular weight: 27 kDa. |
|
ICC/IF
1/10. |
靶标
-
相关性
An H6N1 influenza virus was isolated from a green-winged teal during the H5N1 outbreak in Hong Kong Special Administrative Region (SAR) in 1997. This virus possesses similar genes encoding internal proteins as in the human H5N1 and H9N2 influenza viruses. In 1999, influenza viruses from quail infected two humans in Hong Kong, suggesting the potential for avian influenza viruses to cross the species barrier and infect humans without prior reassortment in an intermediate host, such as the pig. The common features shared by H5N1 and H9N2 influenza viruses isolated from humans are the genes encoding the proteins of the replicating complex, the matrix protein (M) gene, the nonstructural protein (NS) gene, N1 neuraminidase (NA), This virus essentially represents the reemergence of the H5N1 influenza viruses with a different hemagglutinin (HA). -
数据库链接
- SwissProt: Q809Z8 Influenza A
-
别名
- M antibody
- M1 antibody
- M1 matrix protein 1 antibody
- Matrix protein 1 antibody
图片
-
Western blot - Anti-Avian Influenza Matrix Protein I antibody (ab25918)All lanes : Anti-Avian Influenza Matrix Protein I antibody (ab25918) at 0.5 µg/ml (Western blot analysis of Avian Flu Matrix Protein 1.)
Lane 1 : Recombinant fusion protein containing amino acids 9-28 (A). at 0.1 µg
Lane 2 : Fusion partner without these amino acids (B).
Predicted band size: 27 kDa -
Immunocytochemistry/ Immunofluorescence - Anti-Avian Influenza Matrix Protein I antibody (ab25918)Immunofluoroscence staining of influenza infected MDCK cells using ab25918 at 1/10 dilution. Image courtesy of Catherine Thompson, The University of Reading.
实验方案
数据表及文件
-
SDS download
-
Datasheet download
文献 (3)
ab25918 被引用在 3 文献中.
- Mizuno K et al. Nicotinic acetylcholine receptors regulate type 1 inositol 1,4,5-trisphosphate receptor expression via calmodulin kinase IV activation. J Neurosci Res 93:660-5 (2015). Flow Cyt ; Human . PubMed: 25430056
- Lin SC et al. Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles. PLoS One 7:e39075 (2012). WB . PubMed: 22720032
- Pan YS et al. Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation. J Biomed Biotechnol 2010:506363 (2010). WB . PubMed: 21197092